WANTAI BIOLOGICAL(SH:603392) Mei Ri Shang Bao·2025-09-26 22:19Core Viewpoint - The launch of China's first domestically developed nine-valent HPV vaccine in Zhejiang marks a significant advancement in cervical cancer prevention, providing a more affordable option for women aged 9 to 45 [2][4]. Group 1: Vaccine Details - The vaccine is priced at 499 yuan per dose, which is only 40% of the cost of imported counterparts, significantly lowering the barrier for vaccination [2]. - The vaccine utilizes an advanced E. coli expression system, breaking international monopolies and making China the second country capable of independently supplying high-priced HPV vaccines [2]. - Clinical studies published in The Lancet Infectious Diseases confirm that the vaccine's immune response and safety are comparable to imported vaccines, with a 100% protection rate against persistent infections caused by HPV types 52 and 58, which are prevalent among Asian women [2]. Group 2: Vaccination Program - The vaccination schedule has been optimized: a two-dose regimen for females aged 9-17 and a three-dose regimen for those aged 18-45 [3]. - Experts emphasize that while vaccination is crucial, regular HPV testing and TCT screenings are necessary for comprehensive prevention, highlighting the importance of a "vaccine + screening" approach [3]. Group 3: Community Support and Initiatives - Wantai Biological Pharmacy announced a donation of 6,000 doses of bivalent HPV vaccines to the Zhejiang Cancer Foundation to support public welfare activities, particularly for sanitation workers and migrant workers [3]. - The Zhejiang Cancer Foundation has been active for ten years in providing medical assistance and promoting early detection and treatment of cancer, aiming to spread cancer prevention knowledge throughout the province [3]. Group 4: Future Plans - Starting in October, Zhejiang Province will fully implement the vaccination program for the nine-valent HPV vaccine, aiming to increase vaccination coverage and contribute to the World Health Organization's goal of cervical cancer elimination [4].